Midazolam Versus Lorazepam Potency
Midazolam and lorazepam are both benzodiazepines, and “potency” cannot be stated as a single universal mg-to-mg comparison without specifying the indication and route of administration.[1] For convulsive status epilepticus, commonly used guideline-based first-line dosing treats IM midazolam and IV lorazepam as equivalent options rather than making a direct statement that one is inherently more potent.[1]
Medication Selection Algorithm
- IM midazolam (adult weight >40 kg: 10 mg) is used as a first-line benzodiazepine option for convulsive status epilepticus.[1]
- IV lorazepam (0.1 mg/kg, maximum single dose 4 mg) is used as an equivalent first-line benzodiazepine option for convulsive status epilepticus.[1]
Key Evidence Supporting This Recommendation
- In a comparative evidence report summarizing an American Epilepsy Society guideline treatment algorithm for convulsive status epilepticus, equivalent first-line benzodiazepine options are specified as IM midazolam 10 mg (for adults >40 kg) or IV lorazepam 0.1 mg/kg (max 4 mg).[1]
- Adult seizure cessation before arrival at the emergency department was 73.9% with IM midazolam (289/391) and 62.4% with IV lorazepam (244/391) in the summarized dataset, with similar safety outcomes discussed in that report.[1]
Monotherapy Versus Combination Therapy
- Midazolam and lorazepam are used as single-agent first-line benzodiazepine monotherapy for initial seizure termination in convulsive status epilepticus algorithms.[1]
Important Clarifications or Nuances
- Comparing “potency” between midazolam and lorazepam requires context because onset, duration, and clinically effective dose differ by route (IM vs IV) and indication.[1]
Initiation Thresholds or Indications
- The equivalence cited above applies to the emergency management of convulsive status epilepticus using guideline-based first-line benzodiazepine dosing.[1]
Common Pitfalls to Avoid
- Using a generic mg conversion between midazolam (Versed) and lorazepam (Ativan) without matching the clinical scenario and route of administration can lead to underdosing or overdosing.[1]
Targets or Goals of Therapy
- The therapeutic goal in status epilepticus algorithms is rapid seizure cessation using a guideline-specified benzodiazepine regimen rather than a dose-normalized comparison of intrinsic potency.[1]